This multicentre, randomised, double-blind, placebo-controlled trial enrolled 4228 patients with reduced left ventricular function (ejection fraction <35%) but without symptomatic heart failure.
The addition of enalapril to the conventional heart failure treatment resulted in a significant 37% decrease in the incidence of heart failure.
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.